We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OCGN market cap is 218.46M. The company's latest EPS is USD -0.2165 and P/E is -3.46.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 6.04M | 1.01M | 1.14M | 1.14M |
| Operating Income | -15.42M | -8.62M | -12.22M | -15.45M | -13.25M |
| Net Income | -14.16M | -9.49M | -11.92M | -15.28M | -12.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 43k | 0 | 0 | 6.04M |
| Operating Income | -14.16M | -21.28M | -58.03M | -84.87M | -65.53M |
| Net Income | -20.24M | -34.37M | -58.37M | -81.35M | -63.08M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 74.69M | 64.55M | 51.79M | 40.54M | 61.94M |
| Total Liabilities | 16.29M | 23.98M | 21.53M | 23.62M | 21.31M |
| Total Equity | 58.4M | 40.56M | 30.26M | 16.93M | 40.63M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 16.81M | 27.38M | 105.76M | 108.63M | 64.55M |
| Total Liabilities | 5.79M | 5.83M | 9.94M | 24.58M | 23.98M |
| Total Equity | 11.02M | 21.55M | 95.82M | 84.05M | 40.56M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.75M | -62.05M | -10.6M | -20.51M | -31.78M |
| Investing | 5.8M | 3.08M | -2.35M | -2.87M | -3.37M |
| Financing | 20.87M | 20.88M | -145k | -100k | 34.69M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.89M | -14.71M | -47.94M | -60.08M | -62.05M |
| Investing | -2.36M | -307k | -1.82M | -16.97M | 3.08M |
| Financing | 25.07M | 31.61M | 120.68M | 59.48M | 20.88M |
| Market Cap | 218.46M |
| Price to Earnings Ratio | -3.46 |
| Price to Sales Ratio | 36.23 |
| Price to Cash Ratio | 5.54 |
| Price to Book Ratio | 5.39 |
| Dividend Yield | - |
| Shares Outstanding | 291.32M |
| Average Volume (1 week) | 4.88M |
| Average Volume (1 Month) | 5.07M |
| 52 Week Change | 44.21% |
| 52 Week High | 2.105 |
| 52 Week Low | 0.495 |
| Spread (Intraday) | 0.01 (1.07%) |
| Company Name | Ocugen Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://ocugen.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
